找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays; Franz J. Hock,Michael K. Pugsley Living reference work 20220th edition

[復制鏈接]
查看: 38864|回復: 63
樓主
發(fā)表于 2025-3-21 17:37:23 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
編輯Franz J. Hock,Michael K. Pugsley
視頻videohttp://file.papertrans.cn/284/283079/283079.mp4
概述A landmark in the continuously changing world of drugs.Essential reading for scientists and managers involved in drug finding, drug development and decision making.Of use for government institutions a
圖書封面Titlebook: Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;  Franz J. Hock,Michael K. Pugsley Living reference work 20220th edition
描述.The third edition of ‘Drug Discovery and Evaluation’ presents an expanded and updated version of one of the classic reference handbooks on safety and pharmacokinetic assays. Each assay description is sufficiently outlined and equipped with outstanding literature references. This comprehensive handbook mainly addresses the needs of pharmacological institutes and research groups working in this area..
出版日期Living reference work 20220th edition
關鍵詞Bioanalytical Assays; Clinical Studies; Safety Assays; Safety Pharmacokinetics; Safety Pharmacology; Safe
doihttps://doi.org/10.1007/978-3-030-73317-9
isbn_ebook978-3-030-73317-9
The information of publication is updating

書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays影響因子(影響力)




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays影響因子(影響力)學科排名




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays網絡公開度




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays網絡公開度學科排名




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays被引頻次




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays被引頻次學科排名




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays年度引用




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays年度引用學科排名




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays讀者反饋




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-22 00:03:54 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:53:48 | 只看該作者
地板
發(fā)表于 2025-3-22 05:00:21 | 只看該作者
Magnetic Resonance Imaging in Pharmaceutical Safety Assessment,arkers identified in preclinical safety assessment studies for use in clinical drug safety studies..Imaging technologies provide powerful insights into the biological effects of pharmaceuticals and can contribute important biomarkers that aid in the development of new therapies to treat disease.
5#
發(fā)表于 2025-3-22 08:57:45 | 只看該作者
Biomaterials in Their Role in Creating New Approaches for the Delivery of Drugs, Proteins, Nucleic al-based drug delivery system is unique to the drug, peptide, or protein employed in the system. Therefore, this chapter focuses on the safety considerations along with the therapeutic efficacy offered by this evolving developing area of therapeutics.
6#
發(fā)表于 2025-3-22 16:34:26 | 只看該作者
7#
發(fā)表于 2025-3-22 19:57:01 | 只看該作者
Distribution: Across Barriers,barrier. Meanwhile, there exist several in vitro systems to study drug permeation across this special blood–brain barrier (section “Blood–Brain Barrier (BBB)”). They cover primary cultures of brain endothelial cells in monoculture or as coculture with astrocytes or pericytes (section “Primary Cultur
8#
發(fā)表于 2025-3-22 21:20:18 | 只看該作者
Drug Safety Assessment,. Guidelines hereby serve to optimize and facilitate development of harmonized desirable standards to optimize research and regulations, and to accelerate their implementation..The aim of this article is to summarize the complex procedures needed to create guidelines and to support their use. The ma
9#
發(fā)表于 2025-3-23 01:43:39 | 只看該作者
10#
發(fā)表于 2025-3-23 09:13:41 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-6 10:51
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
河池市| 潼南县| 黔南| 神池县| 顺平县| 甘孜县| 齐齐哈尔市| 新河县| 济源市| 易门县| 灵寿县| 吉木乃县| 南阳市| 海丰县| 石棉县| 浮山县| 常山县| 泉州市| 定南县| 沛县| 兴文县| 大足县| 砀山县| 镶黄旗| 隆德县| 习水县| 文昌市| 南陵县| 嫩江县| 台中县| 云梦县| 淮安市| 南溪县| 长岭县| 容城县| 舟山市| 威远县| 保德县| 卢湾区| 汤原县| 昌宁县|